{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-25-000070","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.862688+00:00","generated_at":"2026-05-23T02:37:12.650761+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"GeneDx Q1 revenue $87.1M, exome/genome revenue up 62% YoY; raises FY 2025 guidance","bullets":["Q1 exome/genome revenue $71.4M (+62% YoY); total revenue $87.1M (+42% YoY).","Adjusted net income $7.7M vs loss of $8.0M a year ago; GAAP net loss $6.5M.","Announced plans to acquire Fabric Genomics; no deal value disclosed.","Raised FY 2025 revenue guidance to $360-375M; reaffirms exome/genome growth of at least 30%.","Adjusted gross margin improved to 69% from 61% YoY; cash $160.2M at quarter-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-25-000070","json":"https://secwatch.observer/filing/0001818331-25-000070.json","markdown":"https://secwatch.observer/filing/0001818331-25-000070.md","text":"https://secwatch.observer/filing/0001818331-25-000070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/0001818331-25-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/wgs-20250430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T02:37:12.650761+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}